NCT06886373View on ClinicalTrials.gov

Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Ophthalmology
Interventions
DRUG

Systane Complete

Systane COMPLETE is an artificial tears that contain nano-emulsion of mineral oil and phospholipids.

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER